Pathogenesis of IgA nephropathy: Fact, hypothesis, fantasy

Pediatric Nephrology

Volumn 12, Issue 6, 1998, Pages 498-504

  Waldo, F Bryson ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE COURSE; GENETICS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOTHERAPY; PATHOPHYSIOLOGY; REVIEW;

DISEASE PROGRESSION; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOTHERAPY;

EID: 0032133544     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Monteiro RC, Halbwachs-Mecarelli L, Roque-Barreira MC, Noel L-H, Berger J, Lesavre P (1985) Charge and size of mesangial IgA in IgA nephropathy. Kidney Int 28:666-671
2. Conley ME, Cooper MD, Michael AF (1980) Selective deposition of immunoglobulin Al in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest 66:1432-1436
3. Lai KN, Lai FM, Lo STH, Lam CWK (1988) Light chain composition of IgA in IgA nephropathy. Am J Kidney Dis 11:425-529
4. Harada T, Hobby P, Courteau M, Knight JF, Williams DW (1989) Charge distribution of plasma IgA in IgA nephropathy. Clin Exp Immunol 77:211-214
5. Galla JH (1995) Perspectives in clinical nephrology - IgA nephropathy. Kidney Int 47:377-387
6. Jackson S (1988) Immunoglobulin-antiimmunoglobulin interactions and immune complexes in IgA nephropathy. Am J Kidney Dis 12:425-429
7. Mestecky J, Waldo FB, Britt WJ, Julian BA, Tomana M, Wall Bake AWL van den, Russell MW, Galla JH, Molodoveanu Z, Jackson S (1991) Exogenous antigens deposited in the glomeruli of patients with IgA nephropathy. In: Sakai H, Sakai O, Nomoto Y (eds) Pathogenesis of IgA nephropathy. Harcourt Brace, Tokyo, pp 247-257
8. Jackson S, Dawson LM, Kotler DP (1988) IgA1 is the major immunoglobulin component of immune complexes in the acquired immune deficiency syndrome. J Clin Immunol 8:64-68
9. Wall Bake AWL van den, Daha MR, Ark A van der, Hiemstra PS, Radl J, Es LA van (1988) Serum levels and in vitro production of IgA subclasses in patients with primary IgA nephropathy. Clin Exp Immunol 74:115-120
10. Wall Bake AWL van den, Daha MR, Evers-Schouten J, Es LA van (1988) Serum IgA and the production of IgA by peripheral blood and bone marrow lymphocytes in patients with primary IgA nephropathy. Evidence for the bone marrow as a source of mesangial IgA. Am J Kidney Dis 12:410-414
11. Lai KN, Ho RTH, Lai CKW, Chan CHS, Li PKT (1994) Increase of both circulating Th1 and Th2 T lymphocyte subsets in IgA nephropathy. Clin Exp Immunol 96:116-121
12. DeCaestecker MP, Bottomley M, Telfer BA, Hutchinson TI, Vose BM, Ballardie FW (1993) Detection of abnormal peripheral blood mononuclear cell cytokine networks in human IgA nephropathy. Kidney Int 44:1298-1308
13. Gesualdo L, Lamm ME, Emancipator SN (1990) Defective oral tolerance promotes nephritogenesis in experimental IgA nephropathy induced by oral immunization. J Immunol 145: 3684-3691
14. Allen AC (1995) Abnormal glycosylation of IgA: is it related to the pathogenesis of IgA nephropathy? Nephrol Dial Transplant 10:1121-1123
15. Mestecky J, Tomana M, Crowlely-Nowick PA, Moldoveanu Z, Julian BA, Jackson S (1993) Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib Nephrol 104:172-182
16. Moldoveanu Z, Moro I, Radl J, Thorpe SR, Komiyama K, Mestecky J (1990) Site of catabolism of autologous and heterologous IgA in non-human primates. Scand J Immunol 32: 577-583
17. Tomana M, Kulhavy R, Mestecky J (1988) Receptor-mediated binding and uptake of immunoglobulin A by human liver. Gastroenterology 94:762-770
18. Nokolova EB, Tomana M, Russell MW (1994) The role of the carbohydrate chains in complement (C3) fixation by solid-phase-bound human IgA. Immunology 82:321-327
19. Simon P, Ramée M-P, Autuly V, Laruelle E, Charasse C, Cam G, Ang KS (1994) Epidemiology of primary glomerular disease in a French region. Variations according to period and age. Kidney Int 46:1192-1198
20. Stratta P, Segoloni GP, Canavese C, Sandri L, Mazzucco G, Rocatello D, Manganaro M, Vercellone A (1995) Incidence of biopsy-proven glomerulonephritis in an Italian province. Am J Kidney Dis 27:631-639
21. Sinniah R (1983) Occurrence of mesangial IgA and IgM deposits in a control necropsy population. J Clin Pathol 36: 276-279
22. Tolkoff-Rubin NE, Cosimi AB, Fuller T, Rubin RH, Colvin RB (1978) IgA nephropathy in HLA-identical siblings. Transplantation 26:430-433
23. Rosenberg HG, Vial SU, Martinez LV, Martinez PS, Aguilo JM, Cisternas MM (1995) Berger's disease in living-related donors. Transplant Proc 27:1809-1810
24. Julian BA, Quiggins PA, Thompson JS, Woodford SY, Gleason K, Wyatt RJ (1985) Familial IgA nephropathy: evidence for an inherited mechanism of disease. N Engl J Med 312: 202-208
25. Wyatt RJ, Rivas ML, Julian BA, Quiggins PA, Woodford SY, McMorrow RG, Baehler RW (1987) Regionalization in hereditary IgA nephropathy. Am J Hum Genet 41:36-50
26. O'Connell PJ, Ibels LS, Thomas MA, Harris M, Eckstein RP (1987) Familial Ig A nephropathy: a study of renal disease in an Australian aboriginal family. Aust NZ J Med 17:27-33
27. Hoy WE, Megill DM, Hughson MD (1987) Epidemic renal disease of unknown etiology in the Zuni Indians. Am J Kidney Dis 9:485-496
28. Hoy WE, Hughson MD, Woodruf SD, Megill DM (1988) Mesangial proliferative glomerulonephritis. A detailed study of the Zuni Indians. Indian Health Service Prim Care Prov 13: 23-30
29. Scolari F, Amoroso A, Savoldi S, Prati E, Scaini P, Manganoni A, Borelli I, Mazzola G, Canale L, Sacchi G, et al (1992) Familial occurrence of primary glomerulonephritis: evidence for a role of genetic factors. Nephrol Dial Transplant 7:587-596
30. Levy M, Lesavre P (1992) Genetic factors in IgA nephropathy (Berger's disease). Adv Nephrol 21:23-51
31. Droz D (1976) Natural history of primary glomerulonephritis with mesangial deposits of IgA. Contrib Nephrol 2:150-157
32. Levy M, Gonzalez-Burchard G, Broyer M, Dommergues JP, Foulard M, Sorez J-P, Habib R (1985) Berger's disease in children: natural history and outcome. Medicine (Baltimore) 64: 157-180
33. Hogg RJ, Silva FG, Wyatt RJ, Reisch JS, Argyle C, Savino D (1994) Prognostic indicators in children with IgA nephropathy-report of the Southwest Pediatric Nephrology Study Group. Pediatr Nephrol 8:15-20
34. Hogg RJ, Waldo FB (1996) Advances in treatment: IgA nephropathy. Semin Nephrol 16:511-516
35. Hogg RJ, Browne R for the SPNSG (1993) Prognostication in children with renal disease - with emphasis on IgA nephropathy. Pediatr Nephrol 7:130-131
36. Alamartine E, Sabatier J-C, Guerin C, Berliet J-M, Berthoux F (1991) Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analyses. Am J Kidney Dis 18:12-19
37. Wyatt RJ, Kritchevsky SB, Woodford SY, Miller PM, Roy S III, Holland NH, Jackson E, Bishof NA (1995) IgA nephropathy: long-term prognosis for pediatric patients. J Pediatr 127:913-919
38. Mustonen J, Pasternack A, Rantala I (1983) The nephrotic syndrome in IgA glomerulonephritis: response to corticosteroid therapy. Clin Nephrol 20:172-176
39. Lai KN, Lai FM, Ho CP, Chan KW (1986) Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial. Clin Nephrol 26:174-180
40. Lai KN, Lai FM, Li PKT, Vallance-Owen J (1987) Cyclosporin treatment of IgA nephropathy: a short term controlled trial. BMJ 295:1165-1168
41. Kobayashi Y, Rujii K, Hiki Y, Tateno S, Kurokawa M (1988) Steroid therapy in IgA nephropathy: a retrospective study in heavy proteinuric cases. Nephron 48:12-17
42. Waldo FB, Wyatt RJ, Kelly DR, Herrera GA, Benfield MR, Kohaut EC (1993) Treatment of IgA nephropathy in children: efficacy of alternate-day oral prednisone. Pediatr Nephrol 7:529-532
43. Kobayashi Y, Hiki Y, Kokubo T, Horii A, Tateno S (1996) Steroid therapy during the early stage of progressive IgA nephropathy, a 10-year follow-up study. Nephron 72:237-242
44. Andreoli SP, Bergstein JM (1989) Treatment of severe IgA nephropathy in children. Pediatr Nephrol 3:248-253
45. Goumenos D, Ahuja M, Shortland JR, Brown CB (1995) Can immunosuppressive drugs slow the progression of IgA nephropathy? Nephrol Dial Transplant 10:1173-1181
46. Welch TR, Fryer C, Shely E, Witte DP, Quinlan M (1992) Double-blind, controlled trial of short-term prednisone therapy in immunoglobulin A glomerulonephritis. J Pediatr 121:474-477
47. Rostoker G, Desvaux-Belghiti D, Pilatte Y, Petit-Phar M, Philippon C, Deforges L, Terzidis H, Intrator L, Andre C, Adnot S (1994) High-dose immunoglobulin therapy for severe IgA nephropathy and Henoch-Schönlein purpura. Ann Intern Med 120:476-484
48. Rostoker G, Desvaux-Belghiti D, Pilatte Y, Petit-Phar M, Philippon C, Deforges L, Terzidis H, Intrator L, Andre C, Adnot S (1995) Immunomodulation with low-dose immunoglobulins for moderate IgA nephropathy and Henoch-Schönlein purpura. Nephron 69:327-334
49. Barbiano di Belgiojoso G, Mazzucco G, Casanova S, et al (1986) Steroid-sensitive nephrotic syndrome with mesangial IgA deposits: a separate entity? Am J Nephrol 6:141-145
50. Lai KN, Lai FMM, Chan KW (1986) An overlapping syndrome of IgA nephropathy and lipoid nephrosis. Am J Clin Pathol 86:716-723
51. Sinnassamy P, O'Regan S (1985) Mesangial IgA deposits with steroid responsive nephrotic syndrome: probable minimal lesion nephrosis. Am J Kidney Dis 5:267-269
52. Southwest Pediatric Nephrology Study Group (1985) Association of IgA nephropathy with steroid-responsive nephrotic syndrome. Am J Kidney Dis 3:157-164
53. Hunley TE, Julian BA, Phillips JA, Summar ML, Yoshida H, Horn RG, Brown NJ, Fago A, Ichikawa I, Kon V (1996) Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 49:571-577
54. Hogg RJ, Scientific Planning Committee of IgA Nephropathy Study (1995) A randomized, placebo-controlled, multicenter trial evaluating alternate-day prednisone and fish oil supplement in young patients with immunoglobulin A nephropathy. Am J Kidney Dis 26:792-796
55. D'Amico G, Imbasciati E, Di Belgioioso GB, Bertoli S, Fogazzi G, Ferrario F, Felin G, Ragni A, Colasanti G, Minetti E (1985) Idiopathic IgA mesangial nephropathy. Medicine (Baltimore) 64:49-60
56. Clarkson AR, Seymour AE, Woodroffe AJ, McKenzie PE, Chan YL, Wootton AM (1980) Controlled trial of phenytoin therapy in IgA nephropathy. Clin Nephrol 13:215-218
57. 2-like activity in patients with IgA nephropathy and Henoch-Schönlein purpura. Pediatr Nephrol 3:61-67
58. Donadio JV (1991) Omega-3 polyunsaturated fatty acids: a potential new treatment of immune renal disease. Mayo Clin Proc 66:1018-1028
59. Donadio JV, Bergstralh EJ, Offord K, Spencer D, Holley KE (1994) A controlled trial of fish oil in Ig A nephropathy. N Engl J Med 331:1194-1199
60. Bennett WM, Walker RG, Kincaid-Smith P (1989) Treatment of IgA nephropathy with eicosapentanoic acid (EPA): a two year prospective trial. Clin Nephrol 31:128-131
61. Pettersson EE, Rekola S, Berglund L, Sundqvist KG, Angelin B, Diczfalusy U, Bjorkhem I, Bergstrom J (1994) Treatment of IgA nephropathy with omega-3 polyunsaturated fatty acids: a prospective, double blind, randomized study. Clin Nephrol 41:183-190
62. Wolf G, Neilson EG (1993) Angiotensin II as a renal growth factor. J Am Soc Nephrol 3:1531-1540
63. Fogo A, Yoshida Y, Glick AD, Homma T, Ichikawa I (1988) Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis. J Clin Invest 82:322-330
64. Hunley TE, Julian BA, Phillips JA, Summar ML, Yoshida H, Horn RG, Brown NJ, Fogo A, Ichikawa I, Kon V (1996) Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 49:571-577
65. Cattran DC, Greenwood C, Ritchie S (1994) Long-term benefits of angiotensin converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy. Am J Kidney Dis 23:247-254
66. Niemir ZI, Stein H, Noronha IL, Kruger C, Andrassy K, Ritz E, Waldherr R (1995) PDGF and TGFβ contribute to the natural course of human IgA glomerulonephritis. Kidney Int 48:1530-1541
67. Border W, Noble NA, Yamamoto T, Tomooka S, Kagami S (1992) Antagonists of transferring growth factor-β: a novel approach to treatment of glomerulonephritis and prevention of glomerulosclerosis. Kidney Int 41:566-570
68. Johnson RJ, Raines EW, Floege J, Yoshimura A, Pritzl P, Alpers C, Ross R (1992) Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factors. J Exp Med 175:1413-1416
69. Donadio JV, Grande JP (1997) Immunoglobulin A nephropathy: a clinical perspective. J Am Soc Nephrol 8:1324-1332